ANNALS OF EPIDEMIOLOGY, published by Elsevier Science Inc, stands as a leading journal in the field of epidemiology, with an impressive impact factor that reflects its significant contribution to public health research. With an ISSN of 1047-2797 and an E-ISSN of 1873-2585, the journal has been at the forefront of disseminating high-quality, peer-reviewed research since its inception in 1990. It is consistently ranked in the first quartile (Q1) for epidemiology in 2023, occupying the 29th position out of 148 in the Scopus Medicine category, with a percentage ranking in the 80th percentile. The journal aims to provide a comprehensive platform for the interdisciplinary exchange of pioneering epidemiological studies, exploring diverse health issues and their societal impacts. Researchers, professionals, and students alike will find valuable insights and innovative methodologies within its pages, making it an essential resource for anyone engaged in the study and application of epidemiology. Its headquarters located in the United States (STE 800, 230 Park Ave, New York, NY 10169) further reinforces its influence in the academic community.

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

Lancet Regional Health-Western Pacific is a premier academic journal published by Elsevier, focusing on the diverse and dynamic field of health in the Western Pacific region. With an impressive Q1 ranking across several vital categories such as Geriatrics and Gerontology, Health Policy, Infectious Diseases, and Public Health, this journal is positioned at the forefront of health research and policy development. The journal aims to provide a platform for innovative research, reviews, and opinion pieces that lead to improved health outcomes and influence health policy across this geographically and culturally rich area. Offering open access to its content, Lancet Regional Health-Western Pacific ensures that the latest findings are readily available to researchers, professionals, and policymakers alike, ultimately contributing to the global discourse on health issues. As it continually strives to maintain rigorous publication standards, the journal serves as a crucial resource in promoting evidence-based practices and driving advancements in public health.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, published by the esteemed BMJ PUBLISHING GROUP, stands as a leading journal in the fields of Epidemiology and Public Health. With an impressive impact factor and ranking in the Q1 quartile for both Epidemiology and Public Health categories as of 2023, it significantly contributes to the dissemination of critical research that shapes public health policies and practices globally. The journal has been a vital resource since 1978, continuously providing an academic platform for the latest advancements and discussions pertinent to community health, environmental concerns, and epidemiological studies. Researchers, professionals, and students alike depend on this influential publication for rigorous peer-reviewed articles, thereby enhancing its reputation as one of the top journals in the field. Despite the absence of Open Access options, the journal's scholarly contributions are evident, making it indispensable for anyone engaged in public health and epidemiological research.

Preventing Chronic Disease (ISSN: 1545-1151, E-ISSN: 1545-1151) is a premier open-access journal published by the CENTERS FOR DISEASE CONTROL & PREVENTION in the United States. Since its inception in 2004, this journal has played a vital role in disseminating research focused on the prevention of chronic diseases, offering insights into innovative public health strategies and policies. With a strong commitment to advancing health knowledge, it has achieved a notable impact factor that reinforces its significance—ranking in the Q1 category for both Health Policy and Public Health, Environmental, and Occupational Health as of 2023. With Scopus rankings placing it in the top 13% and 16% in its respective categories, Preventing Chronic Disease serves as a crucial platform for researchers, professionals, and students dedicated to combating chronic conditions. The journal's open-access model ensures that its valuable findings are accessible to a wide audience, fostering collaboration and innovation in public health research and practice.

Health Promotion and Chronic Disease Prevention in Canada - Research Policy and Practice is a leading open-access journal published by the Public Health Agency Canada. This journal, indexed with the ISSN 2368-738X, is dedicated to advancing the field of health promotion while addressing chronic disease prevention in the Canadian context. Since its inception in 2008, it has gained a robust reputation, evidenced by its ranking in the second quartile (Q2) across multiple categories including Epidemiology, Health Policy, and Public Health, Environmental and Occupational Health. With its emphasis on research and policy implications, the journal serves as a critical resource for researchers, healthcare professionals, and students alike, aiming to promote evidence-based practices and driving discussions that shape public health policies. The journal is particularly noted for its triangulation of research findings into actionable strategies, making it relevant for both academic inquiry and practical application. Whether you are seeking to enhance your knowledge or contribute to the discourse on chronic disease prevention, this journal offers a platform for sharing impactful research and innovative ideas.

Iranian Journal of Public Health is a premier publication dedicated to advancing the field of public health research. Established in 2001 and published by the Iranian Scientific Society Medical Entomology, this Open Access journal provides an invaluable platform for disseminating innovative findings and practices aimed at addressing public health challenges both locally and globally. With its roots tracing back to 1973, the journal has evolved through multiple converged years, reflecting a rich history of commitment to the health sciences. Currently categorized in Q3 within Public Health, Environmental, and Occupational Health, as per the 2023 rankings, it ranks 406 out of 665 in the Scopus database, placing it in the 39th percentile. This significant positioning underscores its role in fostering high-quality research that informs policy and enhances community health outcomes. The editorial team is dedicated to upholding rigorous academic standards while embracing diverse perspectives that resonate within the dynamic landscape of public health. It is an essential resource for researchers, professionals, and students alike, fostering collaborative efforts in the relentless pursuit of health equity and sustainability.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

PLOS Medicine, published by the Public Library of Science, stands as a preeminent open-access journal dedicated to advancing global health through impactful research and discourse. Established in 2004, it has maintained its open-access nature, ensuring that groundbreaking studies in medicine, biochemistry, biotechnology, cell biology, and molecular biology remain accessible to a global audience. With an impressive ranking of 14 out of 636 in General Medicine and a remarkable 97th percentile according to Scopus, PLOS Medicine is recognized for its influential contributions to the medical community. The journal not only aims to disseminate high-quality research but also to foster collaboration across disciplines to improve health outcomes worldwide. Researchers, professionals, and students alike can benefit from the wealth of knowledge and innovations presented in this leading journal, making it an essential resource in the field of medical science.